
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>104-268</title>
    </head>

    <body>
        <h1>
        <a href="./104_267.html" rel="external" title="prev">≪</a>
        104-268
        <a href="./104_269.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>60歳男性。脂質異常症及び高血圧症の診断により、現在、処方1による薬物治療を行っている。本日、処方2が追加された。</p>
<p><img alt="" class="alignnone size-full wp-image-844" height="195.29999999999998" loading="lazy" sizes="(max-width: 691px) 100vw, 691px" src="data:;base64,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" width="483.7"/></p>
<p>検査値<br/>血圧 126/76mmHg、血清クレアチニン値 0.9mg/dL、HbA1c 5.9%(NGSP値)、LDL−C 98mg/dL、HDL−C 62mg/dL、TG(トリグリセリド) 220mg/dL</p>
<h4>問268</h4>
<p>処方2を追加した主目的として最も適切なのはどれか。1つ選べ。</p>
<ol><li>LDL−Cの低下</li><li>HDL−Cの上昇</li><li>TGの低下</li><li>血圧の低下</li><li>HbA1cの低下</li></ol>
<h4>問269</h4>
<p>イコサペント酸エチル粒状カプセルを食直後に服用する理由として、正しいのはどれか。1つ選べ。</p>
<ol><li>服薬タイミングをずらすことで、イコサペント酸エチルによるピタバスタチンの肝取り込み阻害を回避するため。</li><li>服薬タイミングをずらすことで、ロサルタンとイコサペント酸エチルの複合体形成を回避するため。</li><li>食事によって胃内容排出速度を低下させることで、イコサペント酸エチルの急激な血中濃度の上昇を避けるため。</li><li>食事によって胃酸分泌が亢進し、イコサペント酸エチルの溶解度が増加するため。</li><li>食事によって分泌された胆汁酸が、イコサペント酸エチルの可溶化を促進するため。</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            問268：3問269：5
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <h4>問268</h4>
<p><span style="font-weight: 400;">処方 2 は EPA です。</span><span style="font-weight: 400;">EPA は高脂血症に用いられます。</span><span style="font-weight: 400;">高脂血症とは、LDLー cho 140mg/dL 以上の「高コレステロール血症」か、TG 150mg/dL 以上の状態のことです。検査値をふまえると、中性脂肪（TG）低下のために用いられていると考えられます。</span></p>
<p><span style="font-weight: 400;">以上より、問 268 の正解は 3 です。</span></p>
<h4>問269</h4>
<p><span style="font-weight: 400;">EPA は、要するに脂肪といえます。食直後に服用することで、食事により分泌された胆汁酸により吸収が促進します。食前にとると吸収が悪くなります。</span></p>
<p><span style="font-weight: 400;">以上より、問269 の正解は 5 です。</span></p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    